Fibroblasts-dependent maturation and phenotype exacerbation of dystrophic hiPSC-derived MYOtissues enables muscle strength evaluation for gene therapy screening https://www.biorxiv.org/content/10.1101/2023.07.26.550063v1?med=mas
Fibroblasts-dependent maturation and phenotype exacerbation of dystrophic hiPSC-derived MYOtissues enables muscle strength evaluation for gene therapy screening https://www.biorxiv.org/content/10.1101/2023.07.26.550063v1?med=mas